You are here : Home / Quarterly Results / ALKEM LABORATORIES LTD

ALKEM LABORATORIES Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 12-Nov-21 Details👇

ALKEM LABORATORIES Quarterly Results

Consolidated Sep2021
Audited
Jun2021
Audited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
Audited
Jun2020
Audited
Mar2020
Audited
Dec2019
UnAudited
Revenues ₹2,800 Cr ₹2,731 Cr ₹2,192 Cr ₹2,318 Cr ₹2,363 Cr ₹1,992 Cr ₹2,049 Cr ₹2,182 Cr
Expenses ₹2,176 Cr ₹2,139 Cr ₹1,901 Cr ₹1,789 Cr ₹1,762 Cr ₹1,470 Cr ₹1,746 Cr ₹1,729 Cr
Operating Income ₹624 Cr ₹593 Cr ₹291 Cr ₹529 Cr ₹600 Cr ₹522 Cr ₹303 Cr ₹453 Cr
Other Income ₹42 Cr ₹47 Cr ₹46 Cr ₹96 Cr ₹36 Cr ₹55 Cr ₹27 Cr ₹28 Cr
Interest ₹12 Cr ₹13 Cr ₹11 Cr ₹13 Cr ₹18 Cr ₹17 Cr ₹14 Cr ₹17 Cr
Depreciation ₹73 Cr ₹71 Cr ₹69 Cr ₹69 Cr ₹70 Cr ₹67 Cr ₹81 Cr ₹59 Cr
Profit Before Tax ₹582 Cr ₹556 Cr ₹258 Cr ₹543 Cr ₹548 Cr ₹493 Cr ₹235 Cr ₹405 Cr
Profit After Tax ₹559 Cr ₹480 Cr ₹249 Cr ₹464 Cr ₹482 Cr ₹423 Cr ₹192 Cr ₹390 Cr
EPS ₹45.53 ₹39.16 ₹20.07 ₹37.72 ₹39.49 ₹35.30 ₹15.79 ₹31.95

Check out Industry Peers

Peers & Returns1W1M1Y
ALKEM LABORATORIES -0.6% -4.2% 22.7%
SUN PHARMACEUTICAL INDUSTRIES -1.1% -5.3% 36.4%
DIVIS LABORATORIES -5.6% -10.5% 28.2%
DR REDDYS LABORATORIES -2.4% -4.1% -6.2%
CIPLA -2.6% -1.7% 17.3%
GLAND PHARMA -3.1% -3.4% 62.5%
PIRAMAL ENTERPRISES 4.5% -4.9% 81.4%
CADILA HEALTHCARE 0.4% -6.6% -0.4%
TORRENT PHARMACEUTICALS 5.5% 8.2% 14.4%

ALKEM LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

2.51 %

Y-o-Y

18.50 %

Quarters Revenues % Change
Sep2021 ₹2,800 Cr
2.51
Jun2021 ₹2,731 Cr
24.60
Mar2021 ₹2,192 Cr
-5.43
Dec2020 ₹2,318 Cr
-1.89
Sep2020 ₹2,363 Cr
18.61
Jun2020 ₹1,992 Cr
-2.78
Mar2020 ₹2,049 Cr
-6.09
Dec2019 ₹2,182 Cr -

ALKEM LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

5.32 %

Y-o-Y

3.98 %

Quarters Operating Profit % Change
Sep2021 ₹624 Cr
5.32
Jun2021 ₹593 Cr
103.66
Mar2021 ₹291 Cr
-44.98
Dec2020 ₹529 Cr
-11.89
Sep2020 ₹600 Cr
15.10
Jun2020 ₹522 Cr
72.16
Mar2020 ₹303 Cr
-33.15
Dec2019 ₹453 Cr -
Operating Margins
Q-o-Q

2.72 %

Y-o-Y

-12.24 %

Quarters Operating Margin% % Change
Sep2021 22.3%
2.72
Jun2021 21.71%
63.48
Mar2021 13.28%
-41.83
Dec2020 22.83%
-10.15
Sep2020 25.41%
-2.98
Jun2020 26.19%
77.08
Mar2020 14.79%
-28.79
Dec2019 20.77% -

ALKEM LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

16.30 %

Y-o-Y

16.00 %

Quarters Profit After Tax % Change
Sep2021 ₹559 Cr
16.30
Jun2021 ₹480 Cr
92.69
Mar2021 ₹249 Cr
-46.27
Dec2020 ₹464 Cr
-3.67
Sep2020 ₹482 Cr
13.78
Jun2020 ₹423 Cr
120.94
Mar2020 ₹192 Cr
-50.88
Dec2019 ₹390 Cr -
PAT Margins
Q-o-Q

13.48 %

Y-o-Y

-2.11 %

Quarters PAT Margin(%) % Change
Sep2021 19.95 %
13.48
Jun2021 17.58 %
54.62
Mar2021 11.37 %
-43.18
Dec2020 20.01 %
-1.82
Sep2020 20.38 %
-4.05
Jun2020 21.24 %
127.17
Mar2020 9.35 %
-47.68
Dec2019 17.87 % -

ALKEM LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

16.27 %

Y-o-Y

15.30 %

Quarters EPS % Change
Sep2021 ₹45.53
16.27
Jun2021 ₹39.16
95.12
Mar2021 ₹20.07
-46.79
Dec2020 ₹37.72
-4.48
Sep2020 ₹39.49
11.87
Jun2020 ₹35.3
123.56
Mar2020 ₹15.79
-50.58
Dec2019 ₹31.95 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

ALKEM LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 1.5% -2% 57.2%
S&P BSE 400 MIDSMALLCAP 1.3% -2.5% 55.9%
S&P BSE MID CAP 1.3% -3% 47.4%
S&P BSE 150 MIDCAP 1.1% -2.6% 52.8%
S&P BSE ALLCAP 0.7% -2.8% 38.3%
S&P BSE 500 0.6% -3% 37.1%
S&P BSE LARGE MIDCAP 0.6% -3.1% 34.2%
S&P BSE 200 0.6% -3.1% 34.8%
S&P BSE 250 LARGEMIDCAP 0.5% -3.1% 35.5%
S&P BSE LOW VOLATILITY 0.5% -3% 23.6%
S&P BSE HEALTHCARE -1.2% -0.5% 20.1%
NSE Indices1W1M1Y
NIFTY MIDCAP 50 1.8% -4.2% 50.4%
NIFTY FREE MIDCAP 100 1.6% -3.3% 52.1%
NIFTY MID SMALL400 1.5% -2.1% 56.5%
NIFTY MIDCAP150 1.2% -2.6% 51.8%
NIFTY500 MULTICAP 50:25:25 1% -2.4% NA
NIFTY LARGE MIDCAP 250 0.8% -2.8% 41.7%
NIFTY 500 0.7% -2.9% 36.9%
NIFTY 200 0.6% -3.1% 34.4%
NIFTY ALPHA QTY VAL LOW-VOL 30 0.2% -3.8% 26.1%
NIFTY ALPHA LOW-VOLATILTY 30 0.1% -2.6% 30.9%
NIFTY QUALITY LOW-VOLATILTY 30 -0.1% -4.2% 24.5%
NIFTY ALPHA QTY LOW-VOLAT.30 -0.4% -3.4% 27.4%
NIFTY PHARMA -0.9% -3% 9.9%
NIFTY HEALTHCARE -1.4% -0.6% NA

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z